NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球神經血管設備市場-預測(2021年∼2026年)

Global Neurovascular Devices Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023188
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
全球神經血管設備市場-預測(2021年∼2026年) Global Neurovascular Devices Market - Forecasts from 2021 to 2026
出版日期: 2021年07月09日內容資訊: 英文 112 Pages
簡介

全球神經血管設備市場規模,預計從2019年的21億3300萬美元到2026年達到34億1600萬美元,在預測期間內預計以6.96%的年度成長率成長。

神經血管設備,用作腦動脈瘤,動靜脈畸形(AVM),頸動脈疾病等的各種神經血管疾病的治療輔助。由於神經血管疾病的患者數增加,以及迅速的治癒時間,併發症的減少,住院期間的縮短等,微創醫療設備受到高度關注,促進這個市場成長。

本報告提供全球神經血管設備市場相關調查,市場概要,以及各類型,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查、亮點

第4章 市場動態

  • 市場促進因素
  • 市場阻礙因素
  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 神經血管設備市場分析:各類型

  • 簡介
  • 栓塞設備
  • 血管成形術和支架置入術設備
  • 神經靜脈通路裝置
  • 腦血栓消除設備

第6章 神經血管設備市場分析:各用途

  • 簡介
  • 狹窄
  • 動靜脈畸形
  • 中風
  • 動脈瘤
  • 其他

第7章 神經血管設備市場分析:各終端用戶

  • 簡介
  • 醫院
  • 門診病人手術中心

第8章 神經血管設備市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 其他
  • 中東、非洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 台灣
    • 印尼
    • 其他

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 企業合併、收購 (M&A)、契約、事業合作
  • 各供應商的競爭力矩陣

第10章 企業簡介

  • Penumbra
  • MicroVention Inc.
  • Stryker
  • Evasc Neurovascular Enterprises
  • Acandis GmbH
  • Memry Corporation
  • Phenox GmbH
  • Spartan Micro Inc.
  • Johnson & Johnson
  • Shape Memory Medical Inc.
目錄
Product Code: KSI061611596

The global neurovascular devices market is expected to grow at a compound annual growth rate of 6.96% over the forecast period to reach a market size of US$3.416 billion in 2026 from US$2.133 billion in 2019. Neurovascular devices are used as an aid in the treatment of various neurovascular disorders such as brain aneurysms, arteriovenous malformations (AVMs), and carotid artery disease. Growth in the market may be attributed to the upsurge in the number of patients suffering from neurovascular diseases and also rising preference for the minimally invasive devices owing to the quick healing time, fewer complications, and short hospital stay.

Increasing geriatric population.

The demand for neurovascular devices is expected to surge due to the rise in the geriatric population, globally. According to the data given by the United Nations, there were around 703 million people, that were aged 65 years or over in the year 2019. The report also stated that the number of older people, worldwide, is expected to double to 1.5 million in the year 2050. An aging population is expected to put significant financial pressure on old-age support systems. During aging, a certain number of factors which include, automatic dysregulation, arterial stiffness, blood-brain barrier, and neurovascular uncoupling are expected to define the dynamics of local perfusion and brain blood flow. The atheromatous disease is a common factor among old age people. With the rise in neurological and neurovascular problems, the demand for neurovascular devices is expected to surge in the coming years.

Rising incidences of the neurovascular diseases to augment the market growth.

The increasing population coupled with the rising geriatric population at the risk of neurovascular diseases will boost the market for neurovascular devices during the given time frame. As per the data by the Center for Disease Control and Prevention (US), 7.4 million people suffered from a stroke in the US. Unhealthy lifestyles have increased the prevalence of the diseases such as hypertension, obesity, diabetes, and high blood cholesterol which have further raised the chances of cerebrovascular disorders, thus, boosting the growth of the neurovascular devices market for the treatment of the disorders. Advancement in the field of neurovascular disorder treatment such as the use of embolization for cerebral AVMs and internal carotid artery stenting for intracranial atherosclerotic disease will also bolster the market growth during the forecast period. However, the growth of the market might be restrained due to the high treatment cost and lack of trained professionals.

The Asia Pacific to be a lucrative market for Neurovascular Devices.

Geographically, North America is estimated to hold the major share in the neurovascular devices market. The major factors driving the growth of the market in the region are the growing and quick adoption of neurovascular devices coupled with the favorable reimbursement policies. Rising awareness among the population regarding neurovascular devices will also boost the market in the region. Asia-Pacific will present a lucrative opportunity for neurovascular devices owing to the rising patient base suffering from diseases such as stenosis, AVM, and strokes along with the improving healthcare infrastructure. Stroke is a major cause of death in the region. According to the data from the National Centre for Healthcare Quality Management in Neurological Diseases in China and other major institutes, the total death rate in China for cerebrovascular diseases was 149.49 per 100,000, and it accounted for more than 1.5 million deaths in the year 2019. Stroke is also a major concern in India. According to the All-India Institute of Medical Sciences, stroke has become the fifth major cause of death in the country in 100,000 population. These developments are expected to accelerate the demand for neurovascular devices in the region, in the coming years.

Latest Developments.

In May 2021, Scientia Vascular, a major developer of interventional medical devices, announced that it had raised US$50 million of financing from a Palo Alto, California-based global healthcare investment firm, called Vivo Capital. The company had stated that the financing would be used to increase marketing, sales, and novel product development in both its flagship neurovascular stroke market and interventional oncology and peripheral vascular markets. This development is expected to enhance the market growth in the coming years.

  • In May 2021, Rapid Medical, an Israeli neurovascular device developer, announced that it had completed an oversubscribed US$50 million series D financing round, which was led by a major firm, MicroPort, with participation from Deep Insight, CITIC private equity fund, and company's existing investors. The company had stated that the investment would be used in the support of the commercial growth of the company's invasive stroke products, globally.
  • In February 2021, Cerus Endovascular Ltd, a privately held medical device company, announced that it had received and got a Breakthrough Device Designation from the United States of Food and Drug Administration, for the company's major Contour Neurovascular System. The novel system would be used in the treatment of intracranial aneurysms. The development is expected to have a positive impact on the market.

Market Segmentation:

  • By Type
  • Embolization Devices
  • Angioplasty and Stenting Devices
  • Neurovascular Access Devices
  • Neurothrombectomy Devices
  • By Applications
  • Stenosis
  • Arteriovenous Malformation
  • Stroke
  • Aneurysms
  • Others
  • By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Taiwan
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Neurovascular Devices Market Analysis, By Type

  • 5.1. Introduction
  • 5.2. Embolization Devices
  • 5.3. Angioplasty and Stenting Devices
  • 5.4. Neurovascular Access Devices
  • 5.5. Neurothrombectomy Devices

6. Neurovascular Devices Market Analysis, By Applications

  • 6.1. Introduction
  • 6.2. Stenosis
  • 6.3. Arteriovenous Malformation
  • 6.4. Stroke
  • 6.5. Aneurysms
  • 6.6. Others

7. Neurovascular Devices Market Analysis, By End-User

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers

8. Neurovascular Devices Market Analysis, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. France
    • 8.4.3. Germany
    • 8.4.4. Italy
    • 8.4.5. Others
  • 8.5. Middle East and Africa
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Thailand
    • 8.6.5. Taiwan
    • 8.6.6. Indonesia
    • 8.6.7. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. Penumbra
  • 10.2. MicroVention Inc.
  • 10.3. Stryker
  • 10.4. Evasc Neurovascular Enterprises
  • 10.5. Acandis GmbH
  • 10.6. Memry Corporation
  • 10.7. Phenox GmbH
  • 10.8. Spartan Micro Inc.
  • 10.9. Johnson & Johnson
  • 10.10. Shape Memory Medical Inc.